EcoDrugPlus

Membrane Metalloendopeptidase

Ensembl ID : ENSEEUG00000001011
Gene Symbol: MME
1 External references
235 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSEEUG00000006498
Gene Symbol: METAP2
1 External references
230 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSEEUG00000002526
Gene Symbol: MAPK1
1 External references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSEEUG00000014380
Gene Symbol: MAPK10
1 External references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSEEUG00000009590
Gene Symbol: MAPK14
1 External references
293 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSEEUG00000011165
Gene Symbol: MAPK3
4 External references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSEEUG00000000032
Gene Symbol: MAPK8
1 External references
292 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSEEUG00000000334
Gene Symbol: MAPK9
1 External references
219 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 10

Ensembl ID : ENSEEUG00000011621
Gene Symbol: MAP3K10
1 External references
186 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 13

Ensembl ID : ENSEEUG00000006576
Gene Symbol: MAP3K13
1 External references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSEEUG00000012993
Gene Symbol: MAP3K5
1 External references
209 Possible Orthologues:

Monoamine Oxidase A

Ensembl ID : ENSEEUG00000005590
Gene Symbol: MAOA
1 External references
148 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).